Published in Amyotroph Lateral Scler Frontotemporal Degener on August 27, 2015
Macular sub-layer thinning and association with pulmonary function tests in Amyotrophic Lateral Sclerosis. Sci Rep (2016) 0.79
Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis. Hum Brain Mapp (2016) 0.77
An eye-tracking controlled neuropsychological battery for cognitive assessment in neurological diseases. Neurol Sci (2017) 0.77
Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis. JAMA Neurol (2016) 0.76
An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS. J Neurol (2017) 0.75
FSL. Neuroimage (2011) 15.56
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 15.38
The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry (2006) 4.73
Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol (2012) 3.04
Amyotrophic lateral sclerosis. AMA Arch Neurol Psychiatry (1953) 2.62
Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol (2000) 2.55
The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry (2011) 2.45
Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain (1992) 2.33
The natural history of primary lateral sclerosis. Neurology (2006) 2.31
Ocular motor function in motor neuron disease. Neurology (1992) 2.27
An fMRI study of the Trail Making Test. Neuropsychologia (2005) 2.24
Administration and interpretation of the Trail Making Test. Nat Protoc (2006) 2.18
Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry (2012) 2.07
Executive control of countermanding saccades by the supplementary eye field. Nat Neurosci (2006) 2.02
Quantitative analysis of attention and detection signals during visual search. J Neurophysiol (2003) 1.99
Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron (2014) 1.90
Frontal lobe atrophy in motor neuron diseases. Brain (1994) 1.76
How fast can you change your mind? The speed of top-down guidance in visual search. Vision Res (2004) 1.75
An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol (2006) 1.73
Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain (2014) 1.67
Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation. Neurology (1997) 1.67
Construct validity in the Trail Making Test: what makes Part B harder? J Clin Exp Neuropsychol (1995) 1.61
Cortical excitability distinguishes ALS from mimic disorders. Clin Neurophysiol (2011) 1.59
Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain (2011) 1.57
Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis. Muscle Nerve (2014) 1.52
Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology (2011) 1.49
Cognitive function in patients with late stage amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2007) 1.49
Decisional role of the dorsolateral prefrontal cortex in ocular motor behaviour. Brain (2003) 1.47
Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol (2013) 1.39
The Trail Making Test: a study in focal lesion patients. Psychol Assess (2001) 1.38
Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (1997) 1.34
Saccade preparation signals in the human frontal and parietal cortices. J Neurophysiol (2007) 1.25
Neuroimaging in amyotrophic lateral sclerosis. Biomark Med (2012) 1.23
Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2012) 1.21
Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain (1996) 1.21
Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis? Amyotroph Lateral Scler (2012) 1.18
Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener (2013) 1.17
Saccadic abnormalities in frontotemporal dementia. Neurology (2012) 1.15
Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. Arch Neurol (2011) 1.15
Frontal eye field activity enhances object identification during covert visual search. J Neurophysiol (2009) 1.13
Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology (2013) 1.13
Amyotrophic lateral sclerosis with ophthalmoplegia. A clinicopathologic study. Arch Neurol (1979) 1.12
Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease. Arch Neurol (2012) 1.07
Brain activations during visual search: contributions of search efficiency versus feature binding. Neuroimage (2003) 1.03
Divergent brain network connectivity in amyotrophic lateral sclerosis. Neurobiol Aging (2012) 1.03
Priming in visual search: separating the effects of target repetition, distractor repetition and role-reversal. Vision Res (2008) 1.03
Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases. J Neurol Neurosurg Psychiatry (2010) 1.00
Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. J Neurol (2005) 0.99
Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry (2001) 0.96
Oculomotor nuclear pathology in amyotrophic lateral sclerosis. Acta Neuropathol (1993) 0.96
Saccade suppression exerts global effects on the motor system. J Neurophysiol (2013) 0.94
Frontal lobe dysfunction in amyotrophic lateral sclerosis. J Neurol Sci (2002) 0.92
Cortical network for gaze control in humans revealed using multimodal MRI. Cereb Cortex (2011) 0.90
Oculomotor function in amyotrophic lateral sclerosis: evidence for frontal impairment. Ann Neurol (1995) 0.90
Development of ophthalmoplegia in amyotrophic lateral sclerosis during long-term use of respirators. J Neurol Sci (1990) 0.90
Ocular fixation instabilities in motor neurone disease. A marker of frontal lobe dysfunction? J Neurol (2009) 0.90
Involvement of prefrontal cortex in visual search. Exp Brain Res (2007) 0.90
Distinct changes in synaptic protein composition at neuromuscular junctions of extraocular muscles versus limb muscles of ALS donors. PLoS One (2013) 0.88
Cognitive functioning in sporadic amyotrophic lateral sclerosis: a six month longitudinal study. J Neurol Neurosurg Psychiatry (2006) 0.88
Primary lateral sclerosis: a neuropsychological study. Neurology (1995) 0.88
Working memory in amyotrophic lateral sclerosis: auditory event-related potentials and neuropsychological evidence. J Clin Neurophysiol (2010) 0.87
Quantitative meta-analysis of fMRI and PET studies reveals consistent activation in fronto-striatal-parietal regions and cerebellum during antisaccades and prosaccades. Front Psychol (2013) 0.87
A neurophysiological analysis of working memory in amyotrophic lateral sclerosis. Brain Res (2011) 0.87
Eye movement in amyotrophic lateral sclerosis: a longitudinal study. Ger J Ophthalmol (1995) 0.87
Cognitive and behavioural deficits associated with the orbitomedial prefrontal cortex in amyotrophic lateral sclerosis. Brain (2010) 0.87
Slow saccades in bulbar-onset motor neurone disease. J Neurol (2010) 0.87
Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population. J Neurol Sci (2011) 0.86
Neuropsychological functioning in PLS: a comparison with ALS. Can J Neurol Sci (2011) 0.85
Activation during the Trail Making Test measured with functional near-infrared spectroscopy in healthy elderly subjects. Neuroimage (2013) 0.85
Abnormalities of visual search behaviour in ALS patients detected with event-related brain potentials. Amyotroph Lateral Scler Other Motor Neuron Disord (1999) 0.84
Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature. Acta Neuropathol (2003) 0.84
The functional oculomotor network and saccadic cognitive control in healthy elders. Neuroimage (2014) 0.84
An eye-tracking version of the trail-making test. PLoS One (2013) 0.83
Neuropsychological changes in patients with primary lateral sclerosis. Amyotroph Lateral Scler (2006) 0.83
Memory deficits in amyotrophic lateral sclerosis are not exclusively caused by executive dysfunction: a comparative neuropsychological study of amnestic mild cognitive impairment. BMC Neurosci (2014) 0.83
Imaging findings associated with cognitive performance in primary lateral sclerosis and amyotrophic lateral sclerosis. Dement Geriatr Cogn Dis Extra (2013) 0.83
Cognitive deterioration and functional compensation in ALS measured with fMRI using an inhibitory task. J Neurosci (2014) 0.81
Extramotor damage is associated with cognition in primary lateral sclerosis patients. PLoS One (2013) 0.80
Cognitive processes in saccade generation. Ann N Y Acad Sci (2005) 0.80
Comparison of phosphorylated TDP-43-positive inclusions in oculomotor neurons in patients with non-ALS and ALS disorders. J Neurol Sci (2012) 0.79
Lockhart Clarke's contribution to the description of amyotrophic lateral sclerosis. Brain (2010) 0.78
Early saccades in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.78
Resistance of extraocular motoneuron terminals to effects of amyotrophic lateral sclerosis sera. Neurology (2000) 0.78
Can executive cognitive measures differentiate between patients with spinal- and bulbar-onset amyotrophic lateral sclerosis? Arch Clin Neuropsychol (2012) 0.78
Abnormal eye movements in Kennedy disease. Neurology (2009) 0.76
A risk stratifying tool to facilitate safe late-stage percutaneous endoscopic gastrostomy in ALS. Amyotroph Lateral Scler Frontotemporal Degener (2017) 0.75